{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:02:11Z","timestamp":1790550131780,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00467-018-3941-3","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T07:36:46Z","timestamp":1521531406000},"page":"1093-1096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-5858","authenticated-orcid":false,"given":"Ulkem Kocoglu","family":"Barlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Serdar","family":"K\u0131ht\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufer","family":"Goknar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Akcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Sevketoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"3941_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fremeaux-Bacchi V, HUS International (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"3941_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10545-010-9161-z","volume":"34","author":"D Martinelli","year":"2011","unstructured":"Martinelli D, Deodato F, Dionisi-Vici C (2011) Cobalamin C defect: natural history, pathophysiology and treatment. J Inherit Metab Dis 34:127\u2013135","journal-title":"J Inherit Metab Dis"},{"key":"3941_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10545-011-9364-y","volume":"35","author":"N Carrilo-Carrasco","year":"2012","unstructured":"Carrilo-Carrasco N, Chandler RJ, Venditti CP (2012) Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 35:91\u2013102","journal-title":"J Inherit Metab Dis"},{"key":"3941_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ped.12953","volume":"58","author":"A Adrovic","year":"2016","unstructured":"Adrovic A, Canpolat N, Caliskan S, Sever L, K\u0131yk\u0131m E, Agbas A, Baumgartner MR (2016) Cobalamin C defect-hemolytic uremic syndrome caused by new mutation in MMACHC. Pediatr Int 58:763\u2013765","journal-title":"Pediatr Int"},{"key":"3941_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00467-016-3399-0","volume":"32","author":"BB Beck","year":"2017","unstructured":"Beck BB, van Spronsen F, Diepstra A, Berger RM, K\u00f6mhoff M (2017) Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity. Pediatr Nephrol 32:733\u2013741","journal-title":"Pediatr Nephrol"},{"key":"3941_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.ajkd.2004.12.004","volume":"45","author":"V Guigonis","year":"2005","unstructured":"Guigonis V, Fr\u00e9meaux-Bacchi V, Giraudier S, Favier R, Borderie D, Massy Z, Mougenot B, Rosenblatt DS, Desch\u00eanes G (2005) Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. Am J Kidney Dis 45:588\u2013595","journal-title":"Am J Kidney Dis"},{"key":"3941_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00467-015-3207-2","volume":"31","author":"C Caillaud","year":"2016","unstructured":"Caillaud C, Zaloszyc A, Licht C, Pichault V, Fremeaux-Bacchi V, Fischbach M (2016) CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol 31:157\u2013161","journal-title":"Pediatr Nephrol"},{"key":"3941_CR8","unstructured":"European Medicines Agency. Soliris (eculizumab): EU summary of product characteristics. Mar 14 \n                    http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/\n                    \n                  human\/ 000791\/WC500054208.pdf"},{"key":"3941_CR9","unstructured":"Alexion Pharmaceuticals Inc.Soliris-(eculizumab):US prescribing information.4\/2014. \n                    http:\/\/www.accessdata.fda.gov\/drugsatfda\/docs\/label\/2014\/125166s368s380lbl.pdf"},{"key":"3941_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, Van de Kar NCAJ, Vande Walle J, Ogawa M, Bedrosian CL, Licht C (2016) Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int 89:701\u2013711","journal-title":"Kidney Int"},{"key":"3941_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2215\/CJN.01090209","volume":"4","author":"CJ Mache","year":"2009","unstructured":"Mache CJ, Acham-Roschitz B, Fremeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312\u20131316","journal-title":"Clin J Am Soc Nephrol"},{"key":"3941_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschenes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562","journal-title":"Clin J Am Soc Nephrol"},{"key":"3941_CR13","first-page":"188","volume":"19","author":"L Guo","year":"2017","unstructured":"Guo L, Lu MP, Dong GJ, Teng LP, Xu YP, Zou LX, Zheng Q (2017) Clinical and laboratory features of macrophage activation syndrome. Zhongguo Dang Dai Er Ke Za Zhi 19:188\u2013192","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"3941_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fped.2014.00097","volume":"2","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T (2014) Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr 2:97","journal-title":"Front Pediatr"},{"key":"3941_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/PEC.0b013e3181e5bffb","volume":"26","author":"K Bechtel","year":"2010","unstructured":"Bechtel K, Iragorri S (2010) Hepatosplenomegaly and reticulocytopenia as prominent features of atypical hemolytic uremic syndrome. Pediatr Emerg Care 26:510\u2013511","journal-title":"Pediatr Emerg Care"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3941-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:23:53Z","timestamp":1553027033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3941-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3941-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}